Structural Demand TailwindsThe company's core market sits within demographic and structural trends that persist over years: aging populations and rising health awareness. Such secular demand supports steady underlying need for medical devices, supplements and services, providing a durable revenue floor independent of short-term cycles.

Diversified Revenue Streams & PartnershipsA multi-channel revenue model—distribution, product sales, and partnerships with providers—reduces single-source risk and strengthens go-to-market reach. Durable partnerships and integrated offerings can sustain margins and customer access over time versus pure-play distributors.

Positive Operating Cash FlowPositive operating cash flow indicates the core business can convert sales into cash despite accounting losses, supporting near-term liquidity and operational continuity. This cash conversion gives management flexibility to fund working capital and execute restructuring or growth initiatives without immediate external financing.

Bears Say

Sharp Revenue DeclineA severe revenue contraction of ~31% materially reduces scale economics and pricing leverage. Sustained top-line decline impairs margin absorption, weakens negotiating power with suppliers and customers, and constrains the firm's ability to invest in product, distribution or technology necessary for medium-term recovery.

Deep Net LossesVery large operating and net losses signal fundamental profitability problems in the core business model. Persistent negative margins erode retained capital, deter strategic partners, and make it difficult to self-fund growth or absorb shocks without restructuring, asset sales or external capital over the medium term.

Negative Shareholders' Equity & High LeverageNegative equity and unusually high leverage indicate financial instability and limited balance-sheet resilience. This raises refinancing, covenant and liquidity risk, potentially forcing dilutive financing or constrained credit access, which undermines long-term strategic options and investment capacity.

8143 FAQ

What was Good Fellow Healthcare Holdings Limited’s price range in the past 12 months?

Good Fellow Healthcare Holdings Limited lowest stock price was HK$0.04 and its highest was HK$0.28 in the past 12 months.

What is Good Fellow Healthcare Holdings Limited’s market cap?

Good Fellow Healthcare Holdings Limited’s market cap is HK$113.86M.

When is Good Fellow Healthcare Holdings Limited’s upcoming earnings report date?

Good Fellow Healthcare Holdings Limited’s upcoming earnings report date is Jun 12, 2026 which is in 109 days.

How were Good Fellow Healthcare Holdings Limited’s earnings last quarter?

Good Fellow Healthcare Holdings Limited released its earnings results on Nov 28, 2025. The company reported -HK$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.002.

Is Good Fellow Healthcare Holdings Limited overvalued?

According to Wall Street analysts Good Fellow Healthcare Holdings Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Good Fellow Healthcare Holdings Limited pay dividends?

Good Fellow Healthcare Holdings Limited does not currently pay dividends.

What is Good Fellow Healthcare Holdings Limited’s EPS estimate?

Good Fellow Healthcare Holdings Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Good Fellow Healthcare Holdings Limited have?

Good Fellow Healthcare Holdings Limited has 1,127,299,900 shares outstanding.

What happened to Good Fellow Healthcare Holdings Limited’s price movement after its last earnings report?

Good Fellow Healthcare Holdings Limited reported an EPS of -HK$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.26%.

Which hedge fund is a major shareholder of Good Fellow Healthcare Holdings Limited?

Currently, no hedge funds are holding shares in HK:8143

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Good Fellow Healthcare Holdings Limited Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

-132.60%

Trailing 12-Months

Asset Growth

-66.27%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Good Fellow Healthcare Holdings Limited

Good Fellow Healthcare Holdings Limited, an investment holding company, provides general hospital services in the People's Republic of China and internationally. Its general hospital services include medical and surgical wards, and medical checkup and examination. As of March 31, 2022, the company operated two general hospitals in Putain and Beijing. It also provides medical investment and hospital management services; and hospital consulting management. The company was formerly known as Hua Xia Healthcare Holdings Limited and changed its name to Good Fellow Healthcare Holdings Limited in February 2019. The company was incorporated in 2001 and is headquartered in Central, Hong Kong. Good Fellow Healthcare Holdings Limited is a subsidiary of Solar Star Global Limited.